Head-to-head · WeighScore
iThriveMD vs Navio MD
By GLP-1 ScorecardUpdated
Score comparison
Navio MD has the higher recorded score — 69.8/100 to 66.7/100.
Navio MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NavioMD offers compounded tirzepatide ($247/mo) plus brand-name Ozempic ($1,199/mo) and Mounjaro ($1,249/mo).
Before you choose
Before comparing the headline prices, the iThriveMD review and the Navio MD review set out what each semaglutide figure in the table below covers, including whether the medication is a brand-name product billed by a pharmacy. Brand-name and compounded prices are different products, so set like against like before treating either one as cheaper.
If neither one fits, iThriveMD vs Nucore Health and Navio MD vs NovoCare Pharmacy compare each of them with another graded program, and the list of alternatives to iThriveMD ranks the programs closest to iThriveMD on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the PlexusDx review covers one graded close to these two, at 67.7/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | iThriveMD | Navio MD |
|---|---|---|
| WeighScore | 66.7/100 | 69.8/100 |
| Grade | C | C |
| Site position | #198 | #126 |
| Semaglutide | $299/mo (starting dose, compounded) | $345/mo (starting dose, brand-name) |
| Tirzepatide | $399/mo (starting dose, compounded) | $189/mo (starting dose, compounded) |
| Coverage | Coverage not published | 48 states |
| Brand-name access | Not confirmed | Yes |
| Oral / sublingual | Not confirmed | Not confirmed |
Strengths
- Compounded semaglutide (from $299/mo) and tirzepatide (from $399/mo), plus microdosing tirzepatide programs
- Lab testing and personalized protocols with a medical team; free initial consultation
- Very thorough legal/policy suite (Terms, Privacy, EUA, Shipping, Returns, CCPA)
- Broad longevity menu: hormones (HRT/TRT), NAD+, peptides, IV therapy, sexual health, diagnostics
What to consider
- Premium pricing — higher than budget compounded-GLP-1 competitors (lowest rates need 'preferred pricing')
- Headline GLP-1 pricing is 'starting at'; full cost depends on dose and program length
- Compounding pharmacy partner not named
- LegitScript certification was not documented on the public pages reviewed
Strengths
- LegitScript verified with board-certified providers and US-licensed pharmacies
- Both compounded and brand-name options
- 48-state coverage
- Hours 9am–10pm EST Mon–Sun
- Transparent tiered pricing: you only pay for your current dose
What to consider
- Not available in Alabama and Mississippi
- Compounded option is tirzepatide only — no compounded semaglutide listed
- Also offers women's HRT (broader platform)
- Pricing is tiered by dose ('as low as'); the entry prices climb as your dose increases
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.